Evofosfamide combined with gemcitabine/nabpaclitaxel in patients with previously untreated locally advanced or metastatic pancreatic adenocarcinoma (PAC): Results of a phase I trial

被引：1
|
作者：
Borad, Mitesh J.
Kwak, Eunice Lee
Wang-Gillam, Andrea
Ibrahim, Ayman
Aldridge, Julie
Olszanski, Anthony J.
机构：
[1] Mayo Clin, Scottsdale, AZ USA
[2] Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USA
[3] Washington Univ, Siteman Canc Ctr, St Louis, MO USA
[4] EMD Serono, Billerica, MA USA
[5] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.4114
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4114
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Gemcitabine/nabpaclitaxel efficacy in elderly patients with metastatic or locally advanced pancreatic adenocarcinoma
    Michalaki, V.
    Poydorou, A.
    Frangulidis, G.
    Vezakis, A.
    Karvouni, E.
    Papadimitriou, C.
    [J]. ANNALS OF ONCOLOGY, 2018, 29 : 44 - 44
  • [2] A phase I/II study of ivaltinostat combined with gemcitabine and erlotinib in patients with untreated locally advanced or metastatic pancreatic adenocarcinoma
    Jo, Jung Hyun
    Jung, Dawoon E.
    Lee, Hee Seung
    Park, Soo Been
    Chung, Moon Jae
    Park, Jeong Youp
    Bang, Seungmin
    Park, Seung Woo
    Cho, Sangsook
    Song, Si Young
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2022, 151 (09) : 1565 - 1577
  • [3] Phase I trial of imexon, Inj. plus gemcitabine in patients with advanced previously untreated pancreatic adenocarcinoma
    Cohen, S. J.
    Zalupski, M.
    Modiano, M.
    Conkling, P.
    Mahadevan, D.
    Wong, L.
    Smith, D.
    Dorr, R. T.
    Boytim, M.
    Hersh, E. M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [4] Phase I trial of gemcitabine combined with radiation for the treatment of locally advanced pancreatic adenocarcinoma
    Wolff, RA
    Evans, DB
    Gravel, DM
    Lenzi, R
    Pisters, PWT
    Lee, JE
    Janjan, NA
    Charnsangavej, C
    Abbruzzese, JL
    [J]. CLINICAL CANCER RESEARCH, 2001, 7 (08) : 2246 - 2253
  • [5] Safety and efficacy of gemcitabine/nabpaclitaxel in elderly patients with metastatic or locally advanced pancreatic adenocarcinoma: a retrospective analysis
    Ventriglia, J.
    Laterza, M. M.
    Savastano, B.
    Petrillo, A.
    Tirino, G.
    Pompella, L.
    Pappalardo, A.
    Orditura, M.
    Ciardiello, F.
    De Vita, F.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [6] Phase II clinical trial of nab-paclitaxel plus gemcitabine in elderly patients with previously untreated locally advanced or metastatic pancreatic adenocarcinoma: the BIBABRAX study
    Jaime Feliu
    Mónica Jorge Fernández
    Teresa Macarulla
    Bartomeu Massuti
    Ana Albero
    José Federico González González
    Guillermo Quintero-Aldana
    Juan Ignacio Delgado-Mingorance
    Ana Fernández Montes
    Carmen García Piernavieja
    Manuel Valladares-Ayerbes
    Ana María López Muñoz
    Rebeca Mondéjar Solís
    Pilar Vicente
    Esther Casado Gonzalez
    Irene González Cebrián
    Guillermo López-Vivanco
    [J]. Cancer Chemotherapy and Pharmacology, 2021, 87 : 543 - 553
  • [7] Phase II clinical trial of nab-paclitaxel plus gemcitabine in elderly patients with previously untreated locally advanced or metastatic pancreatic adenocarcinoma: the BIBABRAX study
    Feliu, Jaime
    Jorge Fernandez, Monica
    Macarulla, Teresa
    Massuti, Bartomeu
    Albero, Ana
    Gonzalez Gonzalez, Jose Federico
    Quintero-Aldana, Guillermo
    Ignacio Delgado-Mingorance, Juan
    Fernandez Montes, Ana
    Garcia Piernavieja, Carmen
    Valladares-Ayerbes, Manuel
    Lopez Munoz, Ana Maria
    Mondejar Solis, Rebeca
    Vicente, Pilar
    Casado Gonzalez, Esther
    Gonzalez Cebrian, Irene
    Lopez-Vivanco, Guillermo
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2021, 87 (04) : 543 - 553
  • [8] Gemcitabine combined with oxaliplatin is safe and effective in patients with previously untreated advanced pancreatic adenocarcinoma
    Baize, N
    Abu Shalaa, A
    Berthier, F
    Demarquay, JFO
    Bernard, JL
    Rahiu, A
    Piche, T
    Huet, PM
    Ran, A
    Caroli-Bosc, FX
    [J]. GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2005, 29 (10): : 1006 - 1009
  • [9] Gemcitabine/nabpaclitaxel in elderly patients with metastatic or locally advanced pancreatic adenocarcinoma: a retrospective analysis on the efficacy and safety profile
    Ventriglia, J.
    Laterza, M. M.
    Savastano, B.
    Petrillo, A.
    Tirino, G.
    Pompella, L.
    Pappalardo, A.
    Orditura, M.
    Ciardiello, F.
    De Vita, F.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [10] MAESTRO: A randomized, double-blind phase III study of evofosfamide (Evo) in combination with gemcitabine (Gem) in previously untreated patients (pts) with metastatic or locally advanced unresectable pancreatic ductal adenocarcinoma (PDAC)
    Van Cutsem, Eric
    Lenz, Heinz-Josef
    Furuse, Junji
    Tabernero, Josep
    Heinemann, Volker
    Ioka, Tatsuya
    Bazin, Igor
    Ueno, Makoto
    Csoszi, Tibor
    Wasan, Harpreet
    Melichar, Bohuslav
    Karasek, Petr
    Macarulla, Teresa Mercade
    Guillen, Carmen
    Kalinka-Warzocha, Ewa
    Horvath, Zsolt
    Prenen, Hans
    Schlichting, Michael
    Ibrahim, Ayman
    Bendell, Johanna C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
12345